0001840498-21-000001.txt : 20210115 0001840498-21-000001.hdr.sgml : 20210115 20210115140755 ACCESSION NUMBER: 0001840498-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210115 DATE AS OF CHANGE: 20210115 EFFECTIVENESS DATE: 20210115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gatehouse Bio, Inc. CENTRAL INDEX KEY: 0001840498 IRS NUMBER: 812225637 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-386501 FILM NUMBER: 21531338 BUSINESS ADDRESS: STREET 1: 35 GATEHOUSE DR. CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 267-858-7631 MAIL ADDRESS: STREET 1: 35 GATEHOUSE DR. CITY: WALTHAM STATE: MA ZIP: 02451 D 1 primary_doc.xml X0708 D LIVE 0001840498 Gatehouse Bio, Inc. 35 Gatehouse Drive WALTHAM MA MASSACHUSETTS 02451 (339) 707-7763 DELAWARE sRNAlytics, Inc. None Corporation true 2017 David W. Salzman, Ph.D. c/o Gatehouse Bio, Inc. 35 Gatehouse Drive Waltham MA MASSACHUSETTS 02451 Executive Officer Director Neal Foster c/o Gatehouse Bio, Inc. 35 Gatehouse Drive Waltham MA MASSACHUSETTS 02451 Executive Officer Director Biotechnology Decline to Disclose 06b false 2020-12-31 false true false 0 5445379 5445379 0 The Total Offering Amount includes the conversion of certain convertible securities previously issued by the Issuer. false 28 0 0 0 false Gatehouse Bio, Inc. /s/ David W. Salzman, Ph.D. David W. Salzman, Ph.D. Chief Executive Officer 2021-01-15